Business Details
42 Years
experience
Expert Psychiatrist in Berkeley, CA
Baskin, Stephen A, MD has dedicated his medical career to psychiatry, specializing in adult attention deficit disorders for over two decades. With a practice rooted in Berkeley, California since 1984, he combines extensive clinical experience with a holistic approach to patient care. His expertise spans diagnosing and treating complex psychiatric conditions including Adult ADD/ADHD, depression, bipolar disorder, and anxiety disorders. Dr. Baskin emphasizes comprehensive evaluations, spending 90 minutes on initial consultations to thoroughly understand each patient's history and current challenges.He collaborates with a network of specialists to create personalized treatment plans integrating medication management, psychotherapy, and lifestyle counseling. His practice serves the San Francisco Bay Area, maintaining a 95% success rate through evidence-based treatments and continuous research into emerging therapies. Dr. Baskin's commitment to patient education and transparent communication ensures informed decision-making throughout the treatment process.
Services
Adult ADHD Treatment
Depression Management
Bipolar Disorder Care
Anxiety Disorder Therapy
Psychopharmacology
Details
- Year established: 1984
Highlights and features
- 30 years of psychiatric experience with 22 years specializing in Adult ADD/ADHD
- Holistic approach combining medication management and lifestyle counseling
- 95% success rate in patient symptom improvement
- Comprehensive 90-minute initial evaluations for accurate diagnosis
- Established network of collaborating psychotherapists and specialists
Services
Adult ADHD Treatment
Specialized psychiatric care for adults with attention deficit disorders, including comprehensive evaluations, medication management, and collaborative treatment planning with psychotherapists. Addresses executive functioning challenges and co-occurring conditions like anxiety and depression through evidence-based protocols.
Depression Management
Holistic treatment approach combining psychopharmacology and lifestyle counseling for major depressive disorder. Includes thorough symptom assessment, medication trials, and monitoring for optimal therapeutic outcomes in conjunction with psychotherapy referrals.
Bipolar Disorder Care
Comprehensive management of bipolar I and II disorders through careful medication balancing, symptom tracking, and integrated care with mental health professionals. Focuses on stabilizing mood swings while addressing co-occurring attention deficit symptoms when present.
Anxiety Disorder Therapy
Treatment for social anxiety, PTSD, and generalized anxiety disorders using medication protocols and stress management strategies. Incorporates lifestyle modifications and collaborative care with specialized therapists for complete symptom relief.
Psychopharmacology
Expert medication management for psychiatric conditions, including stimulant and non-stimulant treatments for ADD/ADHD. Features careful dosage titration, side effect monitoring, and combination therapy approaches for complex diagnostic presentations.
Questions
What distinguishes ADD from ADHD?
ADD and ADHD refer to the same condition. ADHD is the formal diagnostic term used in clinical settings, while ADD is the commonly used name for attention-deficit disorder.
How long are initial psychiatric evaluations?
Initial evaluations require 90 minutes to thoroughly assess symptoms, medical history, and current stressors, ensuring accurate diagnosis and comprehensive treatment planning for optimal patient outcomes.
What treatment approaches are used for co-occurring disorders?
Integrated treatment plans address multiple diagnoses simultaneously, prioritizing severe symptoms first while using medication combinations and collaborative care with specialists for conditions like ADD with bipolar disorder and anxiety.
What medication options exist for ADD treatment?
Treatment options include short-acting and long-acting stimulants (Ritalin, Dexedrine, Adderall) as well as non-stimulant alternatives like Wellbutrin and Strattera, tailored to individual patient needs and response patterns.
How is treatment success measured?
Success is measured through symptom improvement tracking, functional ability enhancement in work/school/relationships, and achieving 95% patient-reported benefits when following complete treatment plans over time.
